Högskolan i Skövde

his.sePublikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • apa-cv
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Clinical Outcome 3 Years After Autologous Chondrocyte Implantation Does Not Correlate With the Expression of a Predefined Gene Marker Set in Chondrocytes Prior to Implantation but Is Associated With Critical Signaling Pathways
Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
Department of Orthopaedics, University Medical Center Utrecht, Utrecht, the Netherlands.
Högskolan i Skövde, Institutionen för biovetenskap. Högskolan i Skövde, Forskningscentrum för Systembiologi. (Bioinformatics)ORCID-id: 0000-0003-4697-0590
Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
Vise andre og tillknytning
2014 (engelsk)Inngår i: The Orthopaedic Journal of Sports Medicine, ISSN 2325-9671, Vol. 2, nr 9, s. 1-14, artikkel-id 2325967114550781Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

BACKGROUND: There is a need for tools to predict the chondrogenic potency of autologous cells for cartilage repair.

PURPOSE: To evaluate previously proposed chondrogenic biomarkers and to identify new biomarkers in the chondrocyte transcriptome capable of predicting clinical success or failure after autologous chondrocyte implantation.

STUDY DESIGN: Controlled laboratory study and case-control study; Level of evidence, 3.

METHODS: Five patients with clinical improvement after autologous chondrocyte implantation and 5 patients with graft failures 3 years after implantation were included. Surplus chondrocytes from the transplantation were frozen for each patient. Each chondrocyte sample was subsequently thawed at the same time point and cultured for 1 cell doubling, prior to RNA purification and global microarray analysis. The expression profiles of a set of predefined marker genes (ie, collagen type II α1 [COL2A1], bone morphogenic protein 2 [BMP2], fibroblast growth factor receptor 3 [FGFR3], aggrecan [ACAN], CD44, and activin receptor-like kinase receptor 1 [ACVRL1]) were also evaluated.

RESULTS: No significant difference in expression of the predefined marker set was observed between the success and failure groups. Thirty-nine genes were found to be induced, and 38 genes were found to be repressed between the 2 groups prior to autologous chondrocyte implantation, which have implications for cell-regulating pathways (eg, apoptosis, interleukin signaling, and β-catenin regulation).

CONCLUSION: No expressional differences that predict clinical outcome could be found in the present study, which may have implications for quality control assessments of autologous chondrocyte implantation. The subtle difference in gene expression regulation found between the 2 groups may strengthen the basis for further research, aiming at reliable biomarkers and quality control for tissue engineering in cartilage repair.

CLINICAL RELEVANCE: The present study shows the possible limitations of using gene expression before transplantation to predict the chondrogenic and thus clinical potency of the cells. This result is especially important as the chondrogenic potential of the chondrocytes is currently part of quality control measures according to European and American legislations regarding advanced therapies.

sted, utgiver, år, opplag, sider
Sage Publications, 2014. Vol. 2, nr 9, s. 1-14, artikkel-id 2325967114550781
HSV kategori
Forskningsprogram
Bioinformatik
Identifikatorer
URN: urn:nbn:se:his:diva-12037DOI: 10.1177/2325967114550781PubMedID: 26535366Scopus ID: 2-s2.0-84979085388OAI: oai:DiVA.org:his-12037DiVA, id: diva2:911922
Merknad

CC BY-NC-ND 3.0

Tilgjengelig fra: 2016-03-14 Laget: 2016-03-14 Sist oppdatert: 2022-05-06bibliografisk kontrollert

Open Access i DiVA

fulltext(1305 kB)118 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 1305 kBChecksum SHA-512
8ffba2e9678c2a9c5c8ac126c7a5936a9c3ec65ce7e85a5af94d8ac0040201d738f4734b9e1223427e8b3ee21e6cc54fae0259efa761baab4d8b4385887284b4
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMedScopus

Person

Synnergren, Jane

Søk i DiVA

Av forfatter/redaktør
Synnergren, Jane
Av organisasjonen
I samme tidsskrift
The Orthopaedic Journal of Sports Medicine

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 118 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 705 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • apa-cv
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf